Leo Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries.

Pharmaceutical

Leo Pharma

Lars Green is a Board Member at [Leo Pharma](/org/leo-pharma). Lars has previously held positions at the LEO Foundation and LEO Holding A/S, [Novozymes](/org/novozymes), DLH Group, and [Novo Nordisk](/org/novo-nordisk). 

Lars Green began their career at [Novo Nordisk](/org/novo-nordisk) in 1999 as Director of Finance and IT. In 2001, they were promoted to Vice President of Corporate Financial Planning, and in 2004, they became Senior Vice President of Finance. From 2014 to 2017, Green served as Senior Vice President at [Novo Nordisk](/org/novo-nordisk) before becoming Executive Vice President in 2017. Lars held this position until 2019 when they left to join [Leo Pharma](/org/leo-pharma) as a Board Member. 

At [Leo Pharma](/org/leo-pharma), Green is responsible for the financial wellbeing of the company. Lars works with the CEO to develop long-term financial goals and strategies and provides oversight of the finance team. In addition, they are responsible for ensuring compliance with all financial regulations.

Lars Green has a M.Sc. in Business Administration from the Aarhus School of Business, a Strategic Leadership Program from [Harvard Business School](/org/harvard-business-school), a Board Academy from Plesner / University of Copenhagen, a Program for Pharmaceutical Executives from Wharton/Windhover, and a PED in Program for Executive Development from IMD (International Institute for Management Development) - Business Programs.

Lars Green

Peter Haahr is currently a Board Member at [Leo Pharma](/org/leo-pharma). Peter has previously served as a Board Member at [HC Andersen Capital](/org/hc-andersen-capital), Symphogen, and [NNIT](/org/nnit). Peter has also been the Chief Financial Officer at [Novo Holdings](/org/novo-as) and a Member of the Advisory Board at Exhalation Technology Ltd.

Peter Haahr began their educational career at [Stanford University](/org/stanford), where they studied directors' consortiums. Peter then went on to study leadership at IMD and finance and accounting at Aarhus University.

Peter Haahr

Signe Maria Christensen has been working in the pharmaceutical industry for over 20 years. Signe started their career as a supervisor at [Lundbeck](/org/lundbeck), before moving on to become a scientist at Santaris Pharma. In 2000, they joined Novo Nordisk A/S as an API coordinator, and then moved to NeuroSearch in 2007, where they became CMC coordinator. In 2011, they were elected as an employee-elected board member at [Leo Pharma](/org/leo-pharma).

Signe Maria Christensen obtained their Doctor of Philosophy (Ph.D.) in Organic Chemistry from the Technical University of Denmark (DTU). Signe then pursued research in organic chemistry at Dyson Perrins Lab at the [University of Oxford](/org/university-of-oxford). In organic synthesis, they worked at [Colorado State University](/org/colorado-state-university). Christensen also holds a Master's degree in Chemical Engineering from DTU. Additionally, they have experience in Board Governance from CBS Executive Fonden and Managing partnerships and strategic alliances from [INSEAD](/org/insead).

Signe Maria Christensen

Dennis Schmidt Pedersen is the EVP of Global People & Communications at [Leo Pharma](/org/leo-pharma). Dennis has over 15 years of experience in Human Resources, and has held positions at some of the leading pharmaceutical companies in the world.

Dennis began their career as a Human Resource Manager at Ferring Pharmaceuticals A/S in 2006. Dennis then moved to Genzyme, where they were responsible for HR in Northern Europe. In 2011, Dennis joined Takeda Pharmaceuticals as Director of Human Resources for Northern Europe.

In 2013, Dennis joined Sobi - Swedish Orphan Biovitrum AB (publ) as Senior Vice President Human Resources, and was responsible for the global HR function. Dennis remained in this role until 2018, when they joined [Leo Pharma](/org/leo-pharma) as EVP of Global People & Communications.

Dennis Schmidt Pedersen began their educational career at the Royal Danish Officers Academy, where they studied leadership, analytical studies, and tactics. Dennis then became a Captain in the Royal Danish Army.

Dennis Schmidt Pedersen works with Sven Hauptmann - EVP, Global Product Supply, Becki Morison - EVP, Global Therapeutic & Value Strategy, and Brian Hilberdink - EVP & President, US. Their manager is Christophe Bourdon, CEO.

Dennis Schmidt Pedersen

Becki Morison is the EVP of Global Therapeutic & Value Strategy at [Leo Pharma](/org/leo-pharma). Becki has over 20 years of experience in the pharmaceutical industry, including stints at [Eli Lilly](/org/eli-lilly) and Company and First Health.

At [Eli Lilly](/org/eli-lilly), Becki served as Vice President of US Immunology, where they were responsible for developing a business to business strategy for the long term care segment and leading national account teams. During their time at [Eli Lilly](/org/eli-lilly), they helped the company exceed sales targets of $600 million.

Before joining [Leo Pharma](/org/leo-pharma), Becki was the Director of Sales and Account Management at First Health, where they managed teams responsible for new sales acquisition and large account management for large Fortune 500 employers and health plans.

Becki Morison has a Bachelor of Arts in Psychology and Religion from [Denison University](/org/denison-university), as well as taking financial accounting courses at the University of Chicago.

They are on a team with Guillaume Clément - EVP, Region Europe, Brian Hilberdink - EVP & President, US, and Philip Eickhoff - EVP & Chief Financial Officer. Their manager is Christophe Bourdon, CEO.

Becki Morison

Christophe Bourdon is the current CEO of [Leo Pharma](/org/leo-pharma). Christophe has also served as the Chief Executive Officer of Orphazyme A/S, Senior Vice President EMEAC at Alexion Pharmaceuticals, Inc., and Senior Vice President, General Manager, U.S. Oncology Business at [Amgen](/org/amgen).

Bourdon began their career in the French Civil Service before joining EADS in Japan as a financial controller. Christophe then moved to [Sanofi](/org/sanofi), where they spent 11 years in various positions, including General Manager of Norway and Financial Controller of Japan. In 2005, they left [Sanofi](/org/sanofi) to join Stallergenes as Corporate Marketing Director.

Bourdon joined [Amgen](/org/amgen) in 2007 as Vice President & General Manager of Germany. Christophe was promoted to Senior Vice President, General Manager, U.S. Oncology Business in 2018 and held this position until 2021 when they left [Amgen](/org/amgen) to become the CEO of Orphazyme A/S. Christophe held this position for one year before returning to [Amgen](/org/amgen) as the CEO of [Leo Pharma](/org/leo-pharma).

Christophe Bourdon has a Master Business Administration from IMD and a Business Degree from ISG Institut Supérieur de Gestion.

Some direct reports include Philip Eickhoff - EVP & Chief Financial Officer, Jörg Möller - EVP, and Guillaume Clément - EVP, Region Europe.

Christophe Bourdon

Philip Eickhoff

Paul Navarre

Brian Hilberdink is the EVP & President, US at [Leo Pharma](/org/leo-pharma). Prior to joining [Leo Pharma](/org/leo-pharma), Brian served as Senior Vice President, Sales at [Novo Nordisk](/org/novo-nordisk) from July 1995 to March 2022. In this role, Brian was responsible for leading the newly formed sales organization, consisting of a team of Area Vice Presidents and more than 2200 sales professionals and educators focused on diabetes, obesity and cardiovascular disease.

Under Brian's leadership, the [Novo Nordisk](/org/novo-nordisk) sales team became a formidable execution machine, utilizing a more agile, entrepreneurial approach that proved successful in the marketplace. Thanks to Brian's vision and leadership, [Leo Pharma](/org/leo-pharma) is well-positioned for continued success in the years to come.



Brian Hilberdink reports to Christophe Bourdon, CEO. Some of their coworkers include Becki Morison - EVP, Global Therapeutic & Value Strategy, Anders Kronborg - CFO, and Jörg Möller - EVP.

Brian Hilberdink

Karsten is responsible for the global end to end supply chain at [Leo Pharma](/org/leo-pharma). He was previously Head Global Supply Chain for Anti-Infectives at [Novartis](/org/novartis).

Karsten Gentner

Martin Starcke

Jakob Felding

Ger Pyne

Sven Hauptmann is the EVP of Global Product Supply at [Leo Pharma](/org/leo-pharma). 

Sven has over 25 years of experience in the pharmaceutical industry, and has been with [Leo Pharma](/org/leo-pharma) for the past 5 years. Prior to joining [Leo Pharma](/org/leo-pharma), Sven spent 17 years at Roche, where they eventually became the SVP / Global Head of Drug Product Manufacturing. 

In this role, Sven was responsible for the supply of Roche’s biopharmaceutical drug products and finished goods. Sven led and ran 6 manufacturing sites with over 4000 employees, and also managed external partners. Sven supported annual sales of over CHF 42 billion, with an annual operating budget of CHF 1.3 billion. 

During their time at Roche, Sven made a number of key accomplishments, including assuring high safety, supply and quality/compliance performance. Sven also played a pivotal role in starting up the clinical and commercial supply of cell and personalized therapies. In addition, Sven helped transform the company’s network via an employee co-created agile approach to enable more patient focus, autonomous team, empowerment, and higher efficiency. 

Thanks to Sven’s efforts, Roche was able to achieve a number of key results, including a 65% reduction in order lead time, a 50% improvement in right first time, 5% annual productivity improvements and first quartile employee engagement.

Sven Hauptmann has an MBA from Northwestern University - Kellogg School of Management and a Ph.D. in Chemistry from [Technische Universität Darmstadt](/org/technische-universitat-darmstadt). Sven also has various certifications from [LinkedIn](/org/linkedin) in subjects such as coaching for results, artificial intelligence for business leaders, developing emotional intelligence, having a happier workweek, leading with empathy, critical thinking for more effective communication, being assertive and likable, learning to say no with confidence and grace, staying positive in the face of negativity, strategic planning foundations, being a manager people won't leave, and body language for leaders.

A direct report to Sven Hauptmann is and Karsten Gentner - VP, Global Supply Chain. They are on a team with Dennis Schmidt Pedersen - EVP, Global People & Communications, Brian Hilberdink - EVP & President, US, and Philip Eickhoff - EVP & Chief Financial Officer. Their manager is Christophe Bourdon, CEO.

Sven Hauptmann

Elisabeth Svanberg

Jörg Möller

Guillaume Clément

Lene has been with [Leo Pharma](/org/leo-pharma) since 2016, where she joined From L'Oreal. Here she was responsible for the Professional Products Division supply chain out of Copenhagen.

Lene Ekstrøm

Jonas Agnblad

Jesper Brandgaard

Cristina Lage

Jesper Mailind

Franck Maréno

Karin Attermann was a customer service specialist at [Leo Pharma](/org/leo-pharma) from October 1988 to November 2010. Karin is currently an employee-elected board member at [Leo Pharma](/org/leo-pharma).

Karin Attermann attended Syddansk Universitet - University of Southern Denmark and Vestjysk Gymnasium Tarm.

Leo Pharma

Org chart

Teams

Board of Directors

CEO and Executive Team

Leadership Team

Discover similar companies